Precose and Singulair drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Precose (acarbose) and Singulair (montelukast sodium). Common drug interactions include arthralgia among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Precose and Singulair. It is created by eHealthMe based on reports of 40 people who take the same drugs from the FDA, and is updated regularly.

What is Precose?

Precose has active ingredients of acarbose. eHealthMe is studying from 1,189 Precose users. Check the latest studies of Precose.

What is Singulair?

Singulair has active ingredients of montelukast sodium. It is often used in asthma. eHealthMe is studying from 129,752 Singulair users. Check the latest studies of Singulair.



On Aug, 02, 2026

40 people who take Precose and Singulair together, and have interactions are studied.

Precose and Singulair drug interactions.

What are the common drug interactions of Precose and Singulair, by gender? *:

female:

  1. Arthralgia (joint pain)
  2. Back pain
  3. Blood cholesterol increased
  4. Blood glucose increased
  5. Blood pressure increased
  6. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  7. Chest discomfort
  8. Chest pain
  9. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  10. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)

male:

  1. Anxiety
  2. Pain
  3. Cardiomyopathy (weakening of the heart muscle)
  4. Coronary artery stenosis (narrowing of coronary artery)
  5. Haematocrit decreased
  6. Haemoglobin decreased
  7. Pneumonia
  8. Asthenia (weakness)
  9. Depression
  10. Renal failure (kidney dysfunction)

What are the common drug interactions of Precose and Singulair, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Hypoglycaemia (deficiency of glucose in the bloodstream)
  2. Postural orthostatic tachycardia syndrome (abnormal increase in heart rate on becoming upright)
  3. Urticaria (rash of round, red welts on the skin that itch intensely)

40-49:

  1. Abdominal pain upper
  2. Pneumonia
  3. Arthralgia (joint pain)
  4. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  5. Back pain
  6. Blood cholesterol increased
  7. Blood pressure increased
  8. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  9. Chest discomfort
  10. Chest pain

50-59:

  1. Pneumonia
  2. Cardiac failure congestive
  3. Pericardial effusion (fluid around the heart)
  4. Presyncope
  5. Asthenia (weakness)
  6. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  7. Renal failure chronic (long lasting kidney dysfunction)
  8. Headache (pain in head)
  9. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  10. Hypertension (high blood pressure)

60+:

  1. Chronic kidney disease
  2. Rash
  3. Arrhythmia (irregular heartbeat)
  4. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  5. Asthenia (weakness)
  6. Attention deficit/hyperactivity disorder
  7. Autonomic failure syndrome (a degenerative disease of the autonomic nervous system)
  8. Autonomic neuropathy (malfunction of the autonomic nervous system (ans))
  9. Blood glucose fluctuation
  10. Cardiolipin antibody positive

What are the existing conditions these people have? *

  1. Cardiac Disorder: 11 people, 27.50%
  2. Hypoglycemia (low blood sugar): 3 people, 7.50%
  3. Postural Orthostatic Tachycardia Syndrome (abnormal increase in heart rate on becoming upright): 2 people, 5.00%
  4. Post-Traumatic Stress Disorder: 2 people, 5.00%
  5. Pain: 2 people, 5.00%
  6. Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 2 people, 5.00%
  7. Insomnia (sleeplessness): 2 people, 5.00%
  8. Impaired Gastric Emptying: 2 people, 5.00%
  9. Hypersensitivity: 2 people, 5.00%
  10. Dyspnea (difficult or laboured breathing): 2 people, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Precose and Singulair?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Precose and Singulair:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Precose:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Singulair:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Precose and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Singulair and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on acarbose and montelukast sodium (the active ingredients of Precose and Singulair, respectively), and Precose and Singulair (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: